Analysts have recently evaluated Halozyme Therapeutics and provided 12-month price targets. The average target is $66.78, accompanied by a high estimate of $75.00 and a low estimate of $53.00. Holding ...

We recently compiled a list of the 9 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Advanced Micro Devices’ MI300X and AI strategy challenge Nvidia’s monopoly. Learn why AMD stock is a buy with rising demand for AI and chip advancements.

Lam Research was upgraded to Positive from Neutral by the analysts at Susquehanna following its Investor Day in New York City on Wednesday.

Analog Devices led chips stocks higher on Wednesday after its results kept analysts bullish, while Lam Research (LRCX) made key announcements alongside its investor day.

Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

S&P 500 E-Mini futures (ESH25) are up +0.28%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.36% this morning, with ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) is expected to be announcing its earnings results after the market closes on Tuesday, February 18th. Analysts expect the company to announce ...